Form 10-K
LFA-1/ICAM-1 Interaction as a Therapeutic Target in Dry Eye Disease | Journal of Ocular Pharmacology and Therapeutics
Current understanding of the mechanism of action of lifitegrast in DED.... | Download Scientific Diagram
Deeper Insight THERAPY 5 - ANTI-INFLAMMATORY Therapy — Ocular Surface Center Berlin
File:EMA401 Mechanism of Action.jpg - Wikimedia Commons
Xiidra (lifitegrast ophthalmic solution) for the Treatment of Dry Eye Disease - Clinical Trials Arena
Lifitegrast - Wikiwand
Untitled
Targeting Ocular Disorders Sept. Boston - Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
Ophthalmology Management - SIMPLIFYING THE COMPLICATED: OCULAR SURFACE DISEASE AND THE KISS PRINCIPLE
CRSToday | Dry Eye Disease: Integrating Old and New Therapies
Dry eye syndrome: developments and lifitegrast in perspective | OPTH
Lifitegrast API Manufacturer | CAS 1025967-78-5 API Supplier - Dr.Reddys
lifitegrast | 1025967-78-5
Deeper Insight THERAPY 5 - ANTI-INFLAMMATORY Therapy — Ocular Surface Center Berlin
Mechanism of action (MOA) of lifitegrast at the cellular level. ICAM-1... | Download Scientific Diagram
Mechanism of action of lifitegrast. Notes: Lifitegrast blocks ICAM-1... | Download Scientific Diagram
DRY EYE DISEASE
The Development of Lifitegrast to Treat Dry Eye Syndrome • iBiology
Lifitegrast: A novel drug for treatment of dry eye disease. - Abstract - Europe PMC
Antioxidants | Free Full-Text | Evidence of Polyphenols Efficacy against Dry Eye Disease | HTML
These highlights do not include all the information needed to use XIIDRA safely and effectively. See full prescribing information for XIIDRA. XIIDRA® (lifitegrast ophthalmic solution), for topical ophthalmic useInitial U.S. Approval: 2016
U.S. FDA Grants Priority Review to Lifitegrast NDA for the Treatment of Dry Eye Disease in Adults - Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
NDA 208073/S-005 Page 3
An Engineered Contact Lens for Passive and Sustained Release of Lifitegrast, an Anti-Dry Eye Syndrome Drug
An Engineered Contact Lens for Passive and Sustained Release of Lifitegrast, an Anti-Dry Eye Syndrome Drug | bioRxiv
Current understanding of the mechanism of action of lifitegrast in DED.... | Download Scientific Diagram
Lifitegrast, a Novel Integrin Antagonist for Treatment of Dry Eye Disease - ScienceDirect
A Review of Topical Cyclosporine A Formulations—A Disease-Modify | OPTH
